HIV protease inhibitors.
Winslow
D L
DL
DuPont Merck Pharmaceutical Company, Glenolden Laboratory, Pennsylvania 19805, USA.
Otto
M J
MJ
D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology*; D015195:Drug Design; D004352:Drug Resistance, Microbial; D005544:Forecasting; D006678:HIV / Q000187:drug effects* / Q000201:enzymology; D015658:HIV Infections / Q000188:drug therapy*; D016333:HIV Protease / Q000737:chemistry / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D015394:Molecular Structure
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D016333:HIV Protease